These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 9155855

  • 1. Nebulised bronchodilators, corticosteroids, and rhDNase in adult patients with cystic fibrosis.
    Conway SP, Watson A.
    Thorax; 1997 Apr; 52 Suppl 2(Suppl 2):S64-8. PubMed ID: 9155855
    [No Abstract] [Full Text] [Related]

  • 2. Nebulised bronchodilators, antibiotics and rhDNase for children with cystic fibrosis.
    Spencer DA.
    Thorax; 1997 Apr; 52 Suppl 2(Suppl 2):S89-91. PubMed ID: 9155860
    [No Abstract] [Full Text] [Related]

  • 3. Where we are now with rhDNase.
    Geddes DM, Shah PL.
    Lancet; 1999 May 22; 353(9166):1727. PubMed ID: 10347981
    [No Abstract] [Full Text] [Related]

  • 4. Consensus conference: practical applications of Pulmozyme. September 22, 1993.
    Ramsey BW, Dorkin HL.
    Pediatr Pulmonol; 1994 Jun 22; 17(6):404-8. PubMed ID: 8090614
    [No Abstract] [Full Text] [Related]

  • 5. Aerosolized deoxyribonuclease for cystic fibrosis.
    Med Lett Drugs Ther; 1994 Apr 15; 36(920):34-5. PubMed ID: 8145672
    [No Abstract] [Full Text] [Related]

  • 6. What is the cystic fibrosis clinician supposed to do with human recombinant dornase alfa?
    Coates AL.
    J Pediatr; 2001 Dec 15; 139(6):768-70. PubMed ID: 11743499
    [No Abstract] [Full Text] [Related]

  • 7. Comparison of three jet nebulizer aerosol delivery systems used to administer recombinant human DNase I to patients with cystic fibrosis. The Pulmozyme rhDNase Study Group.
    Fiel SB, Fuchs HJ, Johnson C, Gonda I, Clark AR.
    Chest; 1995 Jul 15; 108(1):153-6. PubMed ID: 7606951
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Inhaled bronchodilators and mucolytic agents in cystic fibrosis].
    Le Roux P, Le Luyer B.
    Arch Pediatr; 2003 Sep 15; 10 Suppl 2():358s-363s. PubMed ID: 14671935
    [Abstract] [Full Text] [Related]

  • 10. Multicenter, open-label study of recombinant human DNase in cystic fibrosis patients with moderate lung disease. DNase International Study Group.
    Harms HK, Matouk E, Tournier G, von der Hardt H, Weller PH, Romano L, Heijerman HG, FitzGerald MX, Richard D, Strandvik B, Kolbe J, Kraemer R, Michalsen H.
    Pediatr Pulmonol; 1998 Sep 15; 26(3):155-61. PubMed ID: 9773909
    [Abstract] [Full Text] [Related]

  • 11. Aerosolized recombinant human DNase I for the treatment of cystic fibrosis.
    Shak S.
    Chest; 1995 Feb 15; 107(2 Suppl):65S-70S. PubMed ID: 7842816
    [Abstract] [Full Text] [Related]

  • 12. Use of computerized tomography and chest x-rays in evaluating efficacy of aerosolized recombinant human DNase in cystic fibrosis patients younger than age 5 years: a preliminary study.
    Nasr SZ, Kuhns LR, Brown RW, Hurwitz ME, Sanders GM, Strouse PJ.
    Pediatr Pulmonol; 2001 May 15; 31(5):377-82. PubMed ID: 11340684
    [Abstract] [Full Text] [Related]

  • 13. [Perspective of use of rhDNase and new therapeutics for cystic fibrosis].
    Navarro J, Munck A.
    Arch Pediatr; 1995 Jul 15; 2(7):682-4. PubMed ID: 7663661
    [Abstract] [Full Text] [Related]

  • 14. Statistical analysis of the long-term effects of recombinant human deoxyribonuclease on pulmonary function in cystic fibrosis patients.
    Chen JJ, Hamilton SA.
    J Biopharm Stat; 2000 Aug 15; 10(3):287-97. PubMed ID: 10959912
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Bronchoscopically administered recombinant human DNase for lobar atelectasis in cystic fibrosis.
    Slattery DM, Waltz DA, Denham B, O'Mahony M, Greally P.
    Pediatr Pulmonol; 2001 May 15; 31(5):383-8. PubMed ID: 11340685
    [Abstract] [Full Text] [Related]

  • 19. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group.
    Fuchs HJ, Borowitz DS, Christiansen DH, Morris EM, Nash ML, Ramsey BW, Rosenstein BJ, Smith AL, Wohl ME.
    N Engl J Med; 1994 Sep 08; 331(10):637-42. PubMed ID: 7503821
    [Abstract] [Full Text] [Related]

  • 20. [Clinical development of rhDNase in the United States].
    Eisenberg J.
    Arch Pediatr; 1995 Jul 08; 2(7):674-8. PubMed ID: 7663659
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.